Roger Perlmutter leaves Merck after 7 years, joins board at InsitroRoger Perlmutter has brought a seven-year stint as head of R&D at Merck & Co/MSD to a close, Share XRoger Perlmutter leaves Merck after 7 years, joins board at Insitrohttps://pharmaphorum.com/news/roger-perlmutter-leaves-merck-after-7-years-joins-board-at-insitro/
Indivior ex-CEO could face jail time after opioid convictionThe resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – Share XIndivior ex-CEO could face jail time after opioid convictionhttps://pharmaphorum.com/news/indivior-ex-ceo-could-face-jail-time-after-opioid-conviction/
David Loew swaps Sanofi’s top vaccine job for CEO role at IpsenSanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as Share XDavid Loew swaps Sanofi’s top vaccine job for CEO role at Ipsenhttps://pharmaphorum.com/news/david-loew-swaps-sanofis-top-vaccine-job-for-ceo-role-at-ipsen/
NICE names Gillian Leng as CEO, replacing Andrew DillonNICE has appointed Prof Gillian Leng as its new chief executive, completing its top leadership search after new Share XNICE names Gillian Leng as CEO, replacing Andrew Dillonhttps://pharmaphorum.com/news/nice-names-gillian-leng-as-ceo-replacing-andrew-dillon/
MPs back Nebhrajani as NICE’s new chair after vetting meetingSharmila Nebhrajani has been confirmed as the new chair of the National Institute for Health and Care Excellence Share XMPs back Nebhrajani as NICE’s new chair after vetting meetinghttps://pharmaphorum.com/news/mps-back-nebhrajani-as-nices-new-chair-after-vetting-meeting/
NICE chair nominee Nebhrajani to face MP scrutiny next weekThe UK government’s preferred candidate to chair NICE – Sharmila Nebhrajani OBE – is due to be quizzed Share XNICE chair nominee Nebhrajani to face MP scrutiny next weekhttps://pharmaphorum.com/news/nice-chair-nominee-nebhrajani-to-face-mp-scrutiny-next-week/
Novartis says mid-stage pipeline is setting up strong growth spurtNovartis kicked off its R&D update in London this morning by pledging to bring at least 10 drugs Share XNovartis says mid-stage pipeline is setting up strong growth spurthttps://pharmaphorum.com/news/novartis-says-mid-stage-pipeline-is-setting-up-strong-growth-spurt/
Senate committee backs Hahn as new FDA CommissionerPresident Trump’s pick for the new FDA Commissioner – Stephen Hahn – has picked up the endorsement he Share XSenate committee backs Hahn as new FDA Commissionerhttps://pharmaphorum.com/news/senate-committee-backs-hahn-as-new-fda-commissioner/
ABPI looks internally for new CEO, naming Richard TorbettThe new chief executive of the Association of the British Pharmaceutical Industry (ABPI) will be Dr Richard Torbett Share XABPI looks internally for new CEO, naming Richard Torbetthttps://pharmaphorum.com/news/abpi-looks-internally-for-new-ceo-naming-richard-torbett/
